Cerebropulmonary dysgenetic syndrome

Experimental and Molecular Pathology

Volumn 85, Issue 2, 2008, Pages 112-116

  Shanklin, D Radford ^a   Mullins, Amanda C ^a   Baldwin, Heather S ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

ABCA3 mutation; Bronchopulmonary dysplasia; Cerebral dystrophy; Cerebropulmonary dysgenetic syndrome; Congenital fibrosis of thyroid; Heterozygotic mutation; Lung fibrosis; Respiratory distress syndrome; Retarded cortical neuronal migration; Surfactant deficiency

Indexed keywords

ABC TRANSPORTER; MUTANT PROTEIN; PROTEIN ABCA3; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; ASSISTED VENTILATION; AUTOPSY; BRAIN CORTEX; BRAIN DISEASE; CASE REPORT; CEREBELLUM; CEREBROPULMONARY DYSGENETIC SYNDROME; DYSTROPHY; FIBROSING ALVEOLITIS; GENE MUTATION; GENETIC DISORDER; HUMAN; HUMAN TISSUE; LUNG DYSPLASIA; LUNG FIBROSIS; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; PREMATURITY;

ATP-BINDING CASSETTE TRANSPORTERS; BRONCHOPULMONARY DYSPLASIA; FATAL OUTCOME; HETEROZYGOTE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; MUTATION; PULMONARY SURFACTANTS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SYNDROME;

EID: 52149085000     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2008.04.006     Document Type: Article

References (39)

1. Alapont Puchalt B., and Prosper Sierra M. Hepatic steatosis associated with heterozygotic familial hypobetalipoproteinemia. Gastroenterol. Hepatol. 27 (2004) 256-259
2. Barter R.A., Byrne M.J., and Carter R.F. Pulmonary hyaline membrane: late results of injury to the lung linings. Arch. Dis. Child. 41 (1966) 489-495
3. Bhattacharyya N., and Banerjee S. A variant of DNA polymerase β acts as a dominant negative mutant. Proc. Natl. Acad. Sci. U. S. A. 94 (1997) 10324-10329
4. Bolande R.P., and Klaus M.H. The morphologic demonstration of an alveolar lining layer and its relationship to pulmonary surfactant. Am. J. Pathol. 45 (1964) 449-463
5. Bonikos D.S., Bensch K.G., Northway W.H., and Edwards D.K. Bronchopulmonary dysplasia: the pulmonary pathologic sequel of necrotizing bronchiolitis and pulmonary fibrosis. Human Pathol. 7 (1976) 643-666
6. Bullard J.E., Wert S.E., Whitsett J.A., Dean M., and Nogee L.M. ABCA3 mutations associated with pediatric interstitial lung disease. Am. J. Respir. Crit. Care Med. 172 (2005) 1026-1031
7. Dean M., Rzhetsky A., and Allikmets R. The human ATP-binding cassette (ABC) transporter superfamily. Genome Res. 11 (2001) 1156-1166
8. de la Monte S.M., Hutchins G.M., and Moore G.W. Respiratory epithelial cell necrosis is the earliest lesion of hyaline membrane disease of the newborn. Am. J. Pathol. 123 (1986) 155-160
9. Edwards D.K., Dyer W.M., and Northway W.H. Twelve years' experience with bronchopulmonary dysplasia. Pediatrics 59 (1977) 839-846
10. Erickson A.M., de la Monte S.M., Moore G.W., and Hutchins G.M. The progression of morphologic changes in bronchopulmonary dysplasia. Am. J. Pathol. 127 (1987) 474-484
11. Fujii K., and Nakadate M. Tumor induction by a single subcutaneous injection of N-methyl-N'-nitro-N-nitrosoguanidine and its derivatives in newborn mice. Z. Krebsforsch. 90 (1977) 313-319
12. Glueck C.J., Tracy T., and Wang P. Legg-Calve-Perthes disease, venous and arterial thrombi, and the factor V Leiden mutation in a four-generation kindred. J. Pediatr. Orthop. 27 (2007) 834-837
13. Guala A., Carrera P., Pastore G., Somaschini M., Ancora G., Faldella G., De Filippi P., Ferrero F., Guarino R., and Danesion C. Familial clustering of unexplained transient respiratory distress in 12 newborns from three unrelated families suggests an autosomal-recessive inheritance. Scient. World J. 7 (2007) 1611-1616
14. Herman M., Djelmis J., Troselj Z., and Ivanisevuc M. Pregnancy outcomes in a patient-heterozygous carrier of R506Q mutation of factor V (Leiden). Acta Med. Croat. 60 (2006) 277-280
15. Howling S.J., Northway W.H., Hansell D.M., Moss R.B., Ward S., and Müller N.L. Pulmonary sequelae of bronchopulmonary dysplasia survivors: high-resolution CT findings. AJR 174 (2000) 1323-1326
16. Imperiale D., Cassano D., Pomari F., Cecchi E., Cerrato P., and Buffa C. Ischaemic stroke, factor V Leiden heterozygosity and left atrial thrombosis in sinus rhythm: a case report. Neurol. Sci. 28 (2007) 111-113
17. Kalajian A.H., Turpen K.B., Donovan K.O., Malone J.C., and Callen J.P. Phenylephrine-induced microvascular occlusion syndrome in a patient with a heterozygous factor V Leiden mutation. Arch. Dermatol. 143 (2007) 1314-1317
18. Marchiori A., Mosena L., Prins M.H., and Prandoni P. The risk of recurrent venous thromboembolism among heterozygous carrier of factor V Leiden or prothombin G20210A mutation. Haematologica 92 (2007) 1107-1114
19. Matsumura Y., Ban N., Ueda K., and Inagaki N. Characterization and classification of ATP-binding cassette transporter ABCA3 mutants in fatal surfactant deficiency. J. Biol. Chem. 281 (2006) 34503-34514
20. Mulugeta S., Gray J.M., Notarfrancesco K.L., Gonzales L.W., Koval M., Feinstein S.I., Ballard P.L., Fisher A.B., and Shuman H. Identification of LBM180, a lamellar body limiting membrane protein of alveolar type II cells, as the ABC transporter protein ABCA3. J. Biol. Chem. 277 (2002) 22147-22155
21. Northway W.H., Rosan R.C., and Porter D.Y. Pulmonary disease following respirator therapy of hyaline membrane disease; bronchopulmonary dysplasia. New Engl. J. Med. 276 (1967) 357-368
22. Northway W.H., and Rosan R.C. Radiographic features of pulmonary oxygen toxicity in the newborn: bronchopulmonary dysplasia. Radiology 91 (1968) 49-58
23. Northway W.H., and Rosan R.C. Treatment of hyaline-membrane disease. New Engl. J. Med. 280 (1969) 331
24. Northway W.H. Observations on bronchopulmonary dysplasia. J. Pediatr. 95 (1979) 815-818
25. Northway W.H. Bronchopulmonary dysplasia: then and now. Arch. Dis. Child. 65 (1990) 1076-1081
26. Northway W.H., Moss R.B., Carlisle K.B., Parker B.R., Popp R.L., Pitlick P.T., Eichler I., Lamm R.L., and Brown B.W. Late pulmonary sequelae of bronchopulmonary dysplasia. New Engl. J. Med. 323 (1990) 1834-1836
27. Northway W.H. Bronchopulmonary dysplasia: twenty-five years later. Pediatrics 89 (1992) 969-973
28. Robertson B. The relationship between hyaline membranes of the newborn and the presence of other pulmonary lesions. Acta Paediatr. 52 (1963) 569-574
29. Robertson B. Pulmonary hyaline membranes of the newborn; The structure of the membranes at varying postnatal age. Acta Pathol. Microbiol. Scand. 62 (1964) 581-588
30. Rocca B., Bellacosa A., De Cristofaro R., Neri G., Della Ventura M., Maggiano N., Rumi C., and Landolfi R. Wiskott-Aldrich syndrome: report of an autosomal dominant variant. Blood 87 (1996) 4538-4543
31. Shanklin D.R., and Wolfson S.L. Therapeutic oxygen as a possible cause of pulmonary hemorrhage in premature infants. New Engl. J. Med. 277 (1967) 833-837
32. Shanklin D.R. Oxygen and the lungs of newborn infants. Int. J. Clin. Pharmacol. 5 (1971) 20-25
33. Shanklin D.R. Pathologic studies of fetal thyroid development. In: Becu B.B., and Shulman D.I. (Eds). Advances in Perinatal Thyroidology. Adv. Exp. Med. Biol. 299 (1991) 27-46
34. Shepard F.M., Johnston Jr. R.B., Klatte E.C., Burko H., and Stahlman M. Residual pulmonary findings in clinical hyaline-membrane disease. New Engl. J. Med. 279 (1968) 1063-1071
35. Shulenin S., Nogee L.M., Annilo T., Wert S.E., Whitsett J.A., and Dean M. ABCA3 gene mutations in newborns with fatal surfactant deficiency. New Engl. J. Med. 350 (2004) 1296-1303
36. Somaschini M., Nogee L.M., Sassi I., Danhaive O., Presi S., Boldrini R., Montrasio C., Ferrari M., Wert S.E., and Carrera P. Unexplained neonatal respiratory distress due to congenital surfactant deficiency. J. Pediatr. 150 (2007) 649-653
37. Tachikawa M., Watanabe M., Hori S., Fukaya M., Ohtsuki S., Asashima T., and Terasaki T. Distinct spatio-temporal expression of ABCA and ABCG transporters in the developing and adult mouse brain. J. Neurochem. 95 (2005) 294-304
38. Verdu A., Cazorla M.R., Moreno J.C., and Casado L.F. Prenatal stroke in a neonate heterozygous for factor V Leiden mutation. Brain Develop. 27 (2005) 451-454
39. Wang R.Y., Lelis A., Mirocha J., and Wilcox W.R. Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life. Genet. Med. 9 (2007) 34-45